EarningsQ1 2026 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q1 2026 Earnings Report

0 Followers

MX:ARWR Q1 2026 EPS Results

Actual EPS$4.05

Consensus EPS$0.68

Beat/MissBeat by +$3.37

One Year Ago EPS-$25.56

Actual Revenue$4.86B

Expected Revenue$3.93B

Beat/MissBeat by +$921.23M

YoY Revenue Growth+10461.32%

QuarterQ1 2026

Date02/05/2026

TimeAfter Close

Conference CallThursday, February 5, 2026

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q1 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.52 / -	-2.023	―
Aug 04, 2026	2026 (Q3)	-23.49 / -25.01	-23.173	-7.94% (-1.84)
May 07, 2026	2026 (Q2)	-20.14 / -17.10	50.576	-133.82% (-67.68)
Feb 05, 2026	2026 (Q1)	0.68 / 4.05	-25.564	115.83% (+29.61)
Nov 25, 2025	2025 (Q4)	-2.06 / -2.02	-25.012	91.91% (+22.99)
Aug 07, 2025	2025 (Q3)	-17.51 / -23.17	-25.38	8.70% (+2.21)
May 12, 2025	2025 (Q2)	-3.44 / 50.58	-18.759	369.61% (+69.33)
Feb 10, 2025	2025 (Q1)	-8.75 / -25.56	-22.805	-12.10% (-2.76)
Nov 26, 2024	2024 (Q4)	-20.60 / -25.01	-18.759	-33.33% (-6.25)
Aug 08, 2024	2024 (Q3)	-9.73 / -25.38	-17.655	-43.75% (-7.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed